ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2025

October 24-29, 2025. Chicago, Illinois.

View by Number View by Title View Sessions

Tuesday, October 28, 2025

10:30AM-12:30PM
Abstract Number: 2527
Safety Profile and Impaired Humoral Response to the Recombinant Herpes Zoster Vaccine in Behçet’s Syndrome Patients under Immunosuppression: a Prospective, Randomized, Placebo-Controlled Trial
(2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
10:30AM-12:30PM
Abstract Number: 1939
Salivary Gland Ultrasounds Can Be Read by General Radiologists: A Review Of 4 Years of Reports from an Urban Academic Radiology Department
(1936–1971) Imaging of Rheumatic Diseases Poster
10:30AM-12:30PM
Abstract Number: 1853
SAP Expression in SLE T Cells is Associated with Differentiation Towards Pro-Inflammatory Effector Subsets.
(1830–1854) Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster
10:30AM-12:30PM
Abstract Number: 2123
Sclerostin in Aging Bone and Muscle: A Comparative Study of Osteoporosis, Sarcopenia, and Osteosarcopenia
(2106–2123) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster II
10:30AM-12:30PM
Abstract Number: 1943
Searching for subclinical synovitis and erosions in seropositive palindromic rheumatism: the added value of the ultrasonographic study of feet
(1936–1971) Imaging of Rheumatic Diseases Poster
10:30AM-12:30PM
Abstract Number: 1903
Seasonal and Racial/Ethnic Variation in Achieving Target Uric Acid Levels in Gout Patients on Urate Lowering Therapy in US Veterans in Central California
(1877–1913) Epidemiology & Public Health Poster III
10:30AM-12:30PM
Abstract Number: 2361
Secondary Outcomes from a Series of N-of-1 NSAID Trials in Axial Spondyloarthritis: Functional, Quality-of-Life, and Safety Results from a Bayesian Analysis
(2338–2376) Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster III
10:30AM-12:30PM
Abstract Number: 1974
Serial ferritin as a diagnostic surrogate marker in Hemophagocytic Lymphohistiocytosis (HLH), a retrospective single-center study
(1972–1989) Measures & Measurement of Healthcare Quality Poster II
10:30AM-12:30PM
Abstract Number: 1825
Serum proteomic and single cell RNA sequencing analysis reveals macrophage activation syndrome physiology and widespread complement dysregulation are associated with severe dengue infection in a pediatric cohort
(1809–1829) Pediatric Rheumatology – Basic Science Poster
10:30AM-12:30PM
Abstract Number: 1835
Serum Zonulin As A Biomarker Of Renal Involvement In Systemic Lupus Erythematosus: Shedding Light On The Gut-Kidney Axis
(1830–1854) Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster
10:30AM-12:30PM
Abstract Number: 1797
SEV-101 Exosomes Isolated from Induced Pluripotent Stem Cell – Derived Hyaline Cartilage Tissue – Characterization of Immunomodulatory and Chondro-proliferative Effects In Vitro
(1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster
10:30AM-12:30PM
Abstract Number: 1786
SEV-101, A Regenerative Exosome Therapeutic for the Treatment of Osteoarthritis
(1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster
10:30AM-12:30PM
Abstract Number: 2543
Severe Visual Impairment in Behçet Syndrome in Time: A Comparison of Four Time Periods
(2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
10:30AM-12:30PM
Abstract Number: 1806
Sex differences in knee joint microbial DNA of C57BL/6 mice and the effect of cross-sex microbiome transplantation
(1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster
10:30AM-12:30PM
Abstract Number: 1793
Sex-associated changes to synovial macrophages in the aging joint
(1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster
  • «Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 63
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology